Global Avanafil Market Size, Share and Trends Analysis Report, By Type (50 mg Avanafil, 100 mg Avanafil, and 200 mg Avanafil), By Application (The Young Man, Middle-Aged Person, and Other), Forecast (2022-2028)

The global Avanafil market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Avanafil is a medication used to treat male sexual function issues (impotence or erectile dysfunction-ED). In conjunction with sexual stimulation, avanafil works by increasing blood flow to the penis to assist a man in obtaining and maintaining an erection. The growing geriatric population, as well as patient awareness and education levels, are important factors driving the growth and demand for Erectile Dysfunction drugs such as avanafil.

Various government reforms and public awareness initiatives in developing regions are further contributing to the market’s growth. Rising US FDA approvals are further expected to boost the market growth. For instance, in December 2020, Glenmark Pharma has received final approval from the US Food and Drug Administration for Tadalafil tablets, which are used to treat erectile dysfunction and enlarged prostate.

In March 2019, VIVUS, Inc. a biopharmaceutical company, has received the Russian Federation’s Ministry of Health approval to use 50 mg, 100 mg, and 200 mg avanafil tablets for the treatment of erectile dysfunction (ED). In the Russian Federation, the product will be marketed under the brand name RAZATUS.

Additionally, in June 2020, the lawsuit between Launch Medical and GAINSWave has been settled. They began collaborating to market The Phoenix, a revolutionary home-use acoustic wave device for treating erectile dysfunction.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- VIVUS Inc., Sanofi S.A., Menarini Group, Auxilium Pharmaceuticals, Endo International, JW Pharmaceutical, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Avanafil Market Report by Segment

By Type

• 50 mg Avanafil
• 100 mg Avanafil
• 200 mg Avanafil

By Application

• The Young Man
• Middle-Aged Person
• Other

Global Avanafil Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa